FDA Warns Novacap About 'Serious' Flaws At Chinese Facility
Chemical conglomerate Novacap Group has been warned by the U.S. Food and Drug Administration about a subsidiary's "serious" record-keeping flaws, including employees who relied on their memories instead of documents in...To view the full article, register now.
Already a subscriber? Click here to view full article